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Abstract
The worldwide prevalence of the neglected tropical diseases (NTD) shows the 
diseases are affecting more than 1 billion. The burden of the Neglected tropical 
diseases cost to developing, the burden of the diseases cost to developing economies 
billions of dollars every year. The genomic research in the last decades providing a 
full sequence (some currently in the sequencing pipeline) of genomes of many of the 
organisms including those which are responsible of neglected tropical diseases, may 
help in the management of such diseases. With the human genome being sequenced, 
the understanding of the genomic interaction between human and NTD pathogen 
enable scientists to develop new strategies to prevent and treat these devastating 
diseases. In this context of genomic era, African scientists may interestingly play 
an insider role in order to be part of the history of the elimination of these diseases. 
However, a critical mass of African scientists in genomic area constitutes the first 
step toward this long way in struggle against NTD. Although the challenge is enor-
mous, it is very important to recognize that some African countries and institutions 
are fully committed to develop and strengthen African leadership in genomic area, 
while some are conspicuously absent from this debate. Joining African competences 
and leadership through collaborative activities and moving forward remains the next 
challenge to really impact the control and elimination of the NTD.
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1. Introduction
The neglected tropical diseases (NTDs) are known as a group of bacterial, 
parasitic, viral, and fungal infections strongly associated with poverty with an 
increase overlapping in tropical areas. They occurred particularly in areas affected 
by socioeconomic progress and unfortunately combined with other factors such 
as limited access to safe water and sanitation, chronic hunger, and also in areas 
where vector-transmitted diseases are more frequent. According to the World Bank 
Study, Sub-Saharan Africa population represents the major focus for the NTDs [1] 
and as mentioned from the 2010 Global Burden of Disease Study, NTDs accounted 
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for more than 26 million [2]. Most of the NTDs are well known as ancient diseases 
resulting in humanity concerns for centuries [3]. From the 2020 Roadmap, 20 
NTDs were identified as following: Buruli ulcer, Chagas disease, cysticercosis/
taeniasis, dengue fever, dracunculiasis (guinea worm disease), echinococcosis, 
food-borne trematodiasis, human African trypanosomiasis (HAT) (sleeping sick-
ness), leishmaniasis, leprosy, lymphatic filariasis, onchocerciasis (river blindness), 
rabies, schistosomiasis, soil-transmitted helminthiasis (ascariasis, hookworm, and 
trichuriasis), trachoma, and yaws [4]. The World Health Organization classified 
the NTDs into two mains groups: in one hand the preventive chemotherapy and 
transmission control (PCT) NTDs including prominently lymphatic filariasis, 
onchocerciasis, schistosomiasis, and soil-transmitted helminthiasis while the inno-
vative and intensified disease management (IDM) on the other hand is constitute 
with Buruli ulcer, Chagas disease, human African trypanosomiasis, and leishmani-
asis disease that are currently lack suitable tools for large scale use [5]. NTDs remain 
as a public health problem for poor populations living in tropical environments and 
difficult-to-access areas with more than 40% of impacted people living in the WHO 
African Region. The challenge is as much as important to justify the development of 
a specific program at WHO AFRO which mission is to provide technical orientation, 
support and guidance to Member States in the WHO African region. The develop-
ment of genomic represents an opportunity that can contribute to the accelerated 
prevention, control, elimination, and eradication of NTDs and neglected zoonoses.
2. Geographical distribution and global burden of the NTDs
The concept, the burden, and the geographical repartition of the NTDs 
(Figure 1) justify the need of a global advocacy including the health policy-makers 
and ultimately the opportunity for tackling the NTDs with the same urgency and 
the commitment as for HIV/AIDS, tuberculosis, and malaria [6].
As previously well described by Hotez [6–8], the NTDs are characterized by the 
following important elements:
• Described as the most common infections of people living in sub-Saharan 
Africa, Asia, and Latin America and the Caribbean where the poverty is known 
as the component.
• NTDs affect about 1.4 billion people who live below the World Bank poverty 
figure of US$1.25 per day.
• Unfortunately, the NTDs result in chronic infections lasting years or even 
decades resulting in a great impact on the affected people family revenue.
• The chronicity of The NTDs affect child growth and intellectual and cognitive 
developments, impair pregnancy outcomes, and decrease worker productivity 
and then the billions of affected people cannot escape poverty.
• Among the consequence, the NTDs also cause blindness and disfigurement 
that are psychologically devastating and result in social stigma.
• This high level of morbidity, economic impairment, and stigma does not 
necessarily translate into large numbers of deaths; overall, the NTDs cause 
high-morbidity but low-mortality conditions.
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Regarding the chronicity of the disease but also as diseases afflicting humankind 
for centuries, NTDs are considered as “non-emerging” disease in contrast to emerg-
ing infections such as HIV/AIDS, SARS, and avian influenza.
Moreover, based on the previous studies, it is well documented that there is a 
geographic overlap among seven of the NTDs (ascariasis, trichuriasis, hookworm 
infection, schistosomiasis, LF, onchocerciasis, and trachoma). This is especially 
observed in sub-Saharan Africa where those NTDs present a very high prevalence. 
However, the overlapping of the NTDs in this part of the world allow to target 
these conditions simultaneously by combining the drugs in an integrated concept 
so named “rapid-impact package” [7, 9], as the drugs can be easily and quickly 
deployed by a contingent of community drug distributors. The rapid-impact pack-
age strategy if well implemented should ultimately contribute to the interruption of 
the diseases transmission such LF, onchocerciasis, and trachoma [9].
3. Impact of NTDs on public health
Although the NTDs are known to severely impact everyone, the diseases affect 
women and girls disproportionately for the following reasons:
Biological and physiological factors of women and girls lead to increased vulner-
ability of this specific category to particular pathologies—for example, female 
genital schistosomiasis and severe helminth-related anemia in pregnant women.
Socio-cultural factors are suspected in increasing risk to NTDs. A specific notified 
example is the water-based domestic activities carried out in two-third Sub-Saharan 
Africa by women or girls which increases risk of diseases such as schistosomiasis, 
whereas child-care and caregiving increases risk of trachoma and blindness. In fact, 
research suggested that women account for 80% of disability-adjusted life years 
linked to trachoma-related blindness.
NTDs that cause disfigurement and disability (such as lymphatic filariasis) can 
have a disproportionately negative impact on employability and marriageability 
Figure 1. 
Global intensity map of EReNTD regions of endemicity. Data are from the World Health Organization (2013).
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of affected women, making them dependent on family members and potentially 
leading to stigmatization and social exclusion.
Indirect impact of NTDs can also disproportionately affect women and girls as 
caregivers, having to give up their jobs or drop out of school in order to take care of 
a sick family member (Figure 2).
4.  Global mobilization and role of scientific commitment against 
neglected tropical disease
The worldwide burden of NTDs lead to a global mobilization with a develop-
ment of a strategic work plan 2014–2020, which has been developed with the 
following objectives: scale up access to NTD-related interventions; enhance 
planning for results, resource mobilization, and financial sustainability of national 
NTD programs; strengthen advocacy, coordination, and national ownership; and 
enhance monitoring, evaluation, surveillance, and research [10] (WHO, 2012): 
Roadmap: accelerating work to overcome the global impact of neglected tropical 
diseases.
The 2020 roadmap against NTD recommend further research including the 
need for newer and safer drugs, vector control, personal hygiene, and the develop-
ment of vaccines. In the implementation of the roadmap, there are several initiative 
including control programs or research initiatives bringing their resources and 
competences. Then, a more macro approach may be necessary to promote greater 
effectiveness in addressing the underlining social, human health, zoonotic, and 
environmental challenges to prevent morbidity, and mortality from these diseases. 
One such approach that is growing worldwide in recognition is the “One Health” 
initiative, a commitment of interdisciplinary and multistakeholder involved locally, 
nationally, and globally in areas of human and animal health, agriculture, and the 
environment [1–15]. However, these one health approaches should be sensitive 
Figure 2. 
A woman washing dishes in a canal. Image credit Anouk Gouvras.
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to resource-poor settings and should leverage partners and broader global public 
health networks as it is represented in Figure 3.
Although there are many NGOs and partners committed in NTDs control, sci-
entific commitment is quite negligible in designing strategies and implementation. 
However, very few of them are from Africa where most of the NTD are present. 
Although African scientist’s mobilization and commitment are well practical in 
some of the NTD control, very few inputs is observed in the genetic and genomic 
area. Indeed, the control and the elimination of certain NTD will be rapidly and 
successfully carried out with the contribution of the understanding of human and 
pathogen genomic interaction. Interestingly genomic constitute the new insight 
generating from genetic studies that can provide explanations and may even allow 
predictions to be made, in the context of a range of biological problems includ-
ing the field of inherited human disorders. The development of the genetic in the 
last decade leads ineluctably to the “genomic” era. Then, importantly, with the 
improvement of sequencing technologies and the enormous reduction in the cost 
of sequencing, biologists are facing with a “data avalanche.” The development of 
the next generation whole exome or genome sequencing may bring to the scientific 
community large possibility of tools to elucidate genetic perturbation occurring in 
many diseases including the neglected tropical diseases. Consequently, genomic 
data analysis may also be useful for the dissection of the genetic mechanisms 
underlying complex polygenic diseases or in understanding how some modi-
fiers genes can influence the age of onset or clinical severity of a given disease 
Figure 3. 
Proposed United Nations “One Health” framework. FAO, Food and Agriculture Organization; OIE, World 
Organization for Animal Health; TDR, WHO Special Programme for Research and Training in Tropical 
Diseases; UNDP, United Nations Development Programme; UNEP, United Nations Environment Programme; 
UNFPA, United Nations Population Fund; UNICEP, United Nations Children's Fund; WHO, World Health 
Organization; WMO, World Meteorological Organization.
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entity. Interestingly, while we are acquiring new research capabilities, we are also 
encountering new problems with the analysis of genomic data such as genomic data 
presentation, format, sharing, and reanalysis.
5.  Programs and strategies ongoing in the field of genomic supporting 
the eradication of neglected tropical disease
The number of emerging infectious diseases is increasing annually despite the 
numerous of effort going on. In parallel to the wide incidence of the infectious 
disease including neglected tropical disease, characterizing novel or re-emerging 
infections is aided by the availability of pathogen genomes. This also helps to 
develop new approaches. Indeed, recently an in silico approach for discovering 
new filarial drug targets was developed in which comparative sequence analysis 
and functional genomics data from the related model nematode Caenorhabditis 
elegans are combined into subtractive filters that can be used to identify poten-
tially essential nematode genes and generate a pool of pre-validated candidate 
targets [15–17]. Different techniques such as the RNA interference (RNAi) 
experiments and other functional studies serve as potential genomic tools to 
examine gene function from NTDs pathogen. Interestingly, sequencing of patho-
gen genomes, can contribute to describing nearly every aspect of transmission 
dynamics when some of the following information, date, location, clinical mani-
festation, or others data regarding the samples origin are including. The analyses 
of these data can positively affect the clinical management of the disease or the 
public health practice such as policies for surveillance, prevention, and treatment. 
The combination of genomic and epidemiological data represents consequently a 
perfect tool to address answers to epidemiological questions and reduce incidence 
and prevalence. How can genomic approaches support neglected tropical disease 
eradication particularly by analogy with how conservation genomics is supporting 
efforts to prevent extinctions. They are genomic approaches of capacity building 
programs in Africa as described through the next paragraphs that are contributing 
to reach this goal demonstrating the opportunity behind this cutting-edge method 
for African scientists.
6. Genomic training programs in Africa
Genomics remain one excellent component in the long way of NTD control and 
elimination. In order to tackle neglected tropical disease and move forward with 
elimination steps, the development of competent resources constitute one of the 
important challenge particularly in Sub-Saharan Africa, where the NTD present 
the highest prevalence. There are few institute in Africa taking the opportunity 
of genomic era that are focused and committed to the development of scientists 
with excellent competence and capacity in genomic. The global effort required to 
apply genomic science and associated technologies to improve the understanding 
of health and disease in diverse populations is undeniable todays. In fact, identify 
individuals and populations who are at risk for developing specific diseases such as 
NTDs, and to better understand underlying genetic and environmental contribu-
tions to risk could greatly contribute in finding sustainable responses. And the 
large diversity of African continent that constitute genetic complexity represents 
an enormous opportunity to utilize such approaches to benefit African populations 
and to inform global health.
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The most involved institution in the training of human resources in genomic 
are Pan African based in South Africa and Nord Africa. Few are developing in west 
Africa mainly in Nigeria, Ghana and recently introduced in Mali.
6.1 H3Africa
The Human Heredity and Health in Africa (H3Africa) constitute one of the larg-
est consortium with the objectives to facilitate fundamental research into diseases 
on the African continent, while also developing infrastructure, resources, training, 
and ethical guidelines to support a sustainable African research enterprise. By his 
constitution, H3Africa is led by African scientists, for the African people. Today, 
H3Africa initiative consists of 48 African projects that include different data set 
from population-based genomic studies of common, non-communicable disorders 
such as heart and renal disease to communicable diseases such as tuberculosis. 
Those studies are designed by African scientists with the objective to identify 
hereditary and environmental contributions to health and disease. While H3Africa 
is working mainly in developing African scientist’s capacity, the consortium is also 
committed to support many crucial capacity building elements, such as ethical, 
legal, and social implications research; training and capacity building for bioinfor-
matics; capacity for biobanking; and coordination and networking (Figure 4).
As a continental consortium, today H3Africa constitutes as one of the most 
important supporting institutions to African researchers and also contributing to 
the establishment of effective collaborations among African researchers. Through 
these different collaborations, the consortium is able to generate specific and 
large data set in relation to the global health. The consortium is supporting dif-
ferent initiative in Africa such the West African Center of Excellence for Global 
Health Bioinformatics Research Training in Mali, the Eastern Africa Network for 
Bioinformatics Training (EANBIT), the Collaborative African Genomics Network” 
(CAfGEN) and the Integrated approach to the identification of genetic determi-
nants of susceptibility to trypanosomiasis (TrypanoGEN) in Uganda.
H3Africa is also collaborating with the African Center of Excellence for 
Genomics of Infectious Diseases (ACEGID) at Redeemer’s University in partnership 
with academic, clinical, and research institutions in Nigeria, Sierra-Leone, and 
Senegal to develop African research capacity in genomics by building a critical mass 
of well-trained scientists.
In order to boost the genomic concept and interest African scientists to this revo-
lutionary scientific area, a group of stakeholders from the H3BiotNet (Pan African 
Bioinformatics Network for H3Africa) and the African Society of Human Genetic 
Figure 4. 
H3Africa, A Pan African network to study genomic and environmental determinants of common diseases of 
African population.
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launched in 2016 in Dakar in Senegal, the African Genomic Medicine Training 
initiative called AGMT.
The African Genomic Medicine Training Initiative (AGMT) was initiated by a 
Working Group made up of volunteers from across the globe with a clear vision to 
“increased effectiveness of Health Care in Africa through the application of Genomic 
Medicine”. This initiative includes several mission:
 Design and develop Genomic Medicine training for African-based healthcare 
professionals.
 Develop competency-based Genomic Medicine curriculum for healthcare work-
ers in Africa.
 Develop and implement flagship training courses based on the collaboratively 
developed curricula.
 The first iteration was run in 2017 with 19 classrooms in 11 countries, 1 online 
class, and 225 students registered.
 The second iteration is running from March to July 2019 as a professional 
development course.
The purpose of this Professional Development Course is to provide genomics 
and genetics education to nurses based in Africa emphasizing the practical applica-
tion of content into learners’ current settings and roles. In addition to contributing 
increasing knowledge in the genetics of African health issues, this second iteration of 
the AGMT initiative aim to develop skills in Genetic counseling, Community engage-
ment/Ethical conduct in research, and patient care and development of health 
promotion material. Therefore, this course seeks to support improved Genetics & 
Genomics knowledge, attitudes and skills for genomic medicine in Africa.
6.2 Genomics Africa
Genomic Africa is a training program organized by the Kwazulu-Natal Research 
Innovation and Sequencing Platform (KRISP) with the aim of “Bringing genomic 
technologies to Africa to fight our great challenges: loss of biodiversity, famine, migration 
and diseases.”
As a Flagship program of the South African Medical Research Council 
(SAMRC), KRIS develops collaboration with DIPLOMICS ASSOCIATED 
LABORATORIES which is a South African Research Infrastructure Roadmap 
(SARIR) program of the Department of Science and Technology (DST). To reach 
his mention, different training programs are developed and run each year at KRISP 
Genomics Africa targeting several diseases including tropical neglected disease as 
well as the development of new technologies to help in Africa including Microbiome 
and Metagenomics Sequencing with Illumina and Nanopore.
There are others genomic training initiatives developed and running in 
Africa, and even not targeting specifically neglected tropical disease are greatly 
contributing to human resources strengthening. By helping strengthen human 
capacity in genomic area, they may help answering how African scientists are 
prepared to tackle the NTDs in the context of genomic era.
6.3 DELGEME
The Developing Excellence in Leadership and Genetics Training for Malaria 
Elimination in sub-Saharan Africa (DELGEME) is a new training programme 
sponsored by the Wellcome Trust Developing Excellence in Leadership, Training 
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and Science Africa (DELTAS Africa) initiative in partnership with the Department 
of International Development (DFID) and the Alliance for Accelerating Excellence 
in Science in Africa (AESA). Led by the University of Science Techniques and 
Technologies of Bamako Mali (USTTB), this genetic and genomic training program 
is partnering with the Medical Research Council (MRC) Unit in The Gambia, The 
United States Army Medical Research Directorate (USAMRD-K)/KEMRI Kenya, 
The Noguchi Memorial Institute for Medical Research (NMIMR)-Navrongo Health 
Research Centre, Ghana, The National Institute of Medical Research (NIMR) 
Tanzania, Université des Sciences de la Santé of Libreville, Gabon, Benhard-
Nocht Institute for Tropical Medicine (BNITM) Germany/Kumasi Centre for 
Collaborative Research (KCCR) Ghana, and the University of Oxford/Wellcome 
Trust Sanger Institute UK. In collaboration with MalariaGEN (www.malariagen.
net) and the Plasmodium Diversity Network, The DELGEME program aims to 
enrich the pool of African Scientists working in African institutions with relevant 
expertise to leverage big genetics and genomics data in the drive for malaria elimi-
nation in sub-Saharan Africa (Figure 5).
In order to reach this objective DELGEME aim to:
To train, retain, and develop Graduates, Doctoral, and Post-doctoral fellows on 
genomics and bioinformatics across malaria endemic countries.
To develop programs to enhance the understanding and dissemination of genetic 
data relevant to malaria interventions and eradication program.
Short-term training will be delivered for various trainees including public health 
officers on genetics, clinical studies, ethics, grant writing, grant management, 
leadership development, etc.
Formal long-term curricula (big data science, biostatistics, health informatics, 
genomics, cell biology, molecular biology, and bioinformatics) will be designed 
and implemented with contribution and oversight from a wide range of local and 
International Faculty and relevant advisory boards.
6.4 Others genomic training institutions/programs in Africa
Interestingly from last year, genomic education is progressively taking off 
in Africa. Indeed, many genomic training programs at the countries or regional 
level are entering in operational phase. Many of them are mainly supported by 
H3ABioNet which organizes a variety of high quality courses and training events 
covering various aspects of bioinformatics from general introductory topics to more 
Figure 5. 
The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan 
Africa (DELGEME) program.
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specialized ones such Next Generation Sequencing and Genome Wide Association 
Studies analyses. Indeed, H3ABioNet is comprised of 28 Nodes distributed among 
17 countries, 16 of which are African.
7. Conclusions
Genomic is a rapidly evolving medical field relying on technological advances 
and with a direct effect on disease treatment, control, and elimination including 
such neglected tropical disease. Nevertheless, in Africa, the introduction, the devel-
opment, and the application of genomic are variously appreciated. Interestingly, 
there are institutions greatly introduced in genomic era and they are working to 
spread the knowledge to the rest of the African continent as pioneers with support 
from some North European and American institutions. Hence, even there is still 
limit critical mass of African scientists well trained in this new scientific domain to 
contribute to the diseases control and elimination in general and neglected tropi-
cal disease in particular, there is room of hope since there is positive signal within 
the continent. However, this provided the strongest possible argument in favor of 
working together in south-south collaboration way on steps to bridge this genomic 
divide. The challenge exists but still remain surmountable.
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